IgA-class anti-beta2-glycoprotein I in women with unexplained recurrent spontaneous abortion.
暂无分享,去创建一个
A. Tsutsumi | T. Koike | S. Fujimoto | H. Yamada | E. Kato | K. Ichikawa | T. Koike | S. Fujimoto | H. Yamada*
[1] M. Mitchell,et al. Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death , 1998, The Lancet.
[2] A. Tsutsumi,et al. IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus. , 1998, The Journal of rheumatology.
[3] A. Tsutsumi,et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus , 1996 .
[4] D. Isenberg,et al. The use of an anti‐β2‐glycoprotein‐I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis , 1995, British journal of haematology.
[5] E. Matsuura,et al. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. , 1995, American journal of obstetrics and gynecology.
[6] T. Yasuda,et al. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface , 1994, The Journal of experimental medicine.
[7] E. Matsuura,et al. β2‐GPI‐dependent and independent binding of anticardiolipin antibodies in patients with recurrent spontaneous abortions , 1994 .
[8] T. Sumida,et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. , 1992, Journal of immunology.
[9] T. Koike,et al. What is the "true" antigen for anticardiolipin antibodies? , 1991, The Lancet.
[10] T. Koike,et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.
[11] T. Barbui,et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.
[12] C. Chesterman,et al. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.